Darmiyan

About:

Darmiyan is developing an AI-powered software platform for early detection, monitoring, and stratification of Alzheimer's disease

Website: https://www.darmiyan.com/

Twitter/X: DarmiyanTech

Top Investors: Y Combinator, UpHonest Capital, Amgen, Center of Aging and Brain Health Innovation, Soma Capital

Description:

Darmiyan has developed a novel, proprietary, patent-protected technology called The Virtual Microscope (Software Algorithm). Using a non-invasive routine clinical brain MRI scan, The Virtual Microscope technology looks into the human brain and localizes and quantifies cell distortion (neurodegeneration) in every voxel of brain MRI generating new brain maps. The first clinical product of this technology is BrainSee, an AI-powered algorithm that has completed a successful third-party validation in the US and Canada establishing a remarkable accuracy and consistency for prognosis of mild cognitive impairment. It is built on over 40 years of cutting-edge neuroscience research combined with advanced medical image analysis and AI, and has received official approval from the late Prof. Paul Greengard, Nobel Laureate in Physiology/ Medicine 2000.